title: Ischemic Stroke Treatment Trials: Neuroimaging Advancements and Implications.
abstract: There have been significant advancements in the treatment of acute ischemic stroke in the last 2 decades. Recent trials have placed a significant emphasis on minimizing the time from symptom onset to stroke treatment by reperfusion therapies, which decreases the cerebral infarct volume and improves clinical outcomes. These clinical advances have paralleled and been aided by advances in neuroimaging. However, controversy remains regarding how much time should be spent on neuroimaging evaluation versus expediting patient treatment. In this review article, we examine the key endovascular stroke trials published in the past 25 years, and we briefly highlight the failures and successes of endovascular stroke trials performed in the past 4 years. We also discuss the advantages and disadvantages of using time from symptom onset versus neuroimaging in determining endovascular stroke therapy candidacy.
authors.affiliation: *Department of Radiology †Department of Radiology, Neuroimaging and Neurointervention Division, Stanford University School of Medicine, Stanford, CA.
authors.forename: Vivek P
authors.initials: VP
authors.lastname: Patel
authors.forename: Jeremy J
authors.initials: JJ
authors.lastname: Heit
mesh_terms: D002545:Brain Ischemia / Q000000981:diagnostic imaging* / Q000628:therapy*; D057510:Endovascular Procedures / Q000379:methods; D006801:Humans; D059906:Neuroimaging / Q000379:methods*; D016032:Randomized Controlled Trials as Topic; D020521:Stroke / Q000000981:diagnostic imaging* / Q000628:therapy*